Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation

HIGHLIGHTS

• who: Xiaomin Ou from the From January , to December, patients with primary non-metastatic, pathologically confirmed NPC were treated with IMRT at Fudan University Shanghai Cancer CenterAll patients were re-staged using the, th edition of the American Joint Committee on Cancer (AJCC) [16]. The details of pretreatment evaluation, treatment, and long-term survival were described in a previous publication [17]. In brief, the, year local recurrence-free survival was, .7% with a median follow-up of, ., months [17]. In this study, only patients with solitary local recurrence as well as local and regional recurrence (, cases) were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.